W1siziisijiwmtyvmtevmdkvmjivmdyvndcvodm4l2ltywdllwjnlmpwzyjdlfsiccisinrodw1iiiwimjawmhg0mdbcdtawm2mixv0

Contributors

About

Formerly Lawrence Harvey Life Sciences, we provide talent on an executive level, contract, permanent and retained basis to SME, big Pharma businesses and incorporating CRO’s & consultancies across the Pharmaceutical, Biotech, Medical Device industries. Our consultants are technically aligned specialists focusing on a single area within Quality, Regulatory Affairs, Clinical Operations & Development, Data Management, Project Management, Medical Affairs, Pharmacovigilance, Market Access & HEOR, Research & Development, Biometrics.

Contact

Statistics

Posts: 118
Reposts: 0

Actelion standing their ground

Another piece of M&A rumour in the news. Employees are becoming accustomed to hearing their company either merging with another or buying...

Read More…

Shionogi: breaking the mould

Shionogi may have started something here...

Instead of focusing purely on newer treatments, Shionogi has decided to revert to older...

Read More…

#saveourNHS

And about time too! Something needs to be done!

For me, as a recruiter in the Medical Affairs market, I speak with medics on a daily...

Read More…

This got me right in the feels...

Not a lot of things like this get to me, but this one managed it. 

Please watch the video and read below. If you watch 90 year old Seesee...

Read More…

Credit where credit is definitely due

February 4th this year marked World Cancer day. Daily, we see fund raisers for Marie Curie / Breast Cancer Now / Cancer Research UK and...

Read More…

Sugar Rush....we need to go further

Sugar has been in the spotlight massively recently and in particular with the new sugary drinks tax, but have we as a society gone far...

Read More…

Recruitment is dead?

Many years ago I faced the objection from prospective clients that they didn't need me because they were advertising their roles direct!...

Read More…

Baxalta, not Taxalta

With the industry still recovering from the shock (although not wholly unexpected) of the "PfizerGan" collapse, the Baxalta/Shire...

Read More…

As a free user, you can follow Passle and like posts.

To repost this post to your own Passle blog, you will need to upgrade your account.

For plans and pricing, please contact our sales team at sales@passle.net

Sorry, you don't have permission to repost or create posts.

Repost successful!

View the repost

Repost successful!

Your repost is currently a draft. Review your repost and request approval.

Something went wrong whilst reposting - please try again.

Sorry - this is not an option. This post already exists in the Passle you have selected.

Try reposting to another Passle.

Select an office:

London New York San Francisco Munich